Jul 13, 2021 / 03:00PM GMT
Jeff Cohen - Ladenburg Thalmann - Analyst
Good morning. This is Jeff Cohen and Destiny Hance from Ladenburg Thalmann. Next up we have Craig Fraser from Windtree Therapeutics. Craig is the President, CEO and Director, and he will be running through a PowerPoint followed by some Q&A. So Craig, thanks for joining us and it's all yours.
Craig Fraser - Windtree Therapeutics, Inc. - CEO
Thank you, Jeff. I appreciate being able to join everybody this morning and give you a little bit of an overview of Windtree and tell you about all that we have going on, which is actually a lot for a small company. I will refer you to our public filings, forward-looking statements, and all of our disclosures.
Also I want to let you know that our deck in full is at www.windtreetx.com, and you can find the deck and download additional information. But just very quickly, Windtree is a Company that -- we have four advanced clinical stage programs. And these programs are focused on really pronounced unmet needs
Windtree Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
